32 studies found for:    Open Studies | Type 1 Diabetes | Denmark
Show Display Options
Rank Status Study
1 Not yet recruiting Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
Conditions: Preeclampsia;   Pregestational Type 1 Diabetes
Intervention:
2 Unknown  The Effect of Metformin in Overweight Patients With Dysregulated Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Tablet Metformin 500 mg
3 Recruiting Liraglutide in Type 1 Diabetes
Conditions: Diabetes Mellitus, Type 1;   Overweight
Interventions: Drug: Liraglutide;   Drug: Placebo
4 Recruiting Effect of CSII and CGM on Progression of Late Diabetic Complications
Condition: Type 1 Diabetes Mellitus
Interventions: Device: Insulin pump therapy (CSII) plus continuous glucose monitoring (CGM);   Other: Multiple daily insulin injections (MDI)
5 Recruiting A Trial Investigating the Effect of Acute Hypoglycaemia on Cognitive Function and Brain Activation Patterns in Subjects With Type 1 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 1
Intervention: Other: glucose clamp
6 Recruiting REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Metformin;   Drug: Placebo
7 Not yet recruiting A Study of LY2605541 and Glargine on Fats in Participants With Type 1 Diabetes
Condition: Diabetes Mellitus, Type 1
Interventions: Biological: LY2605541;   Biological: Insulin Glargine
8 Recruiting The Effect of GLP-1 on the Inhibition of Glucagon Secretion
Conditions: Type 2 Diabetes;   Type 1 Diabetes
Interventions: Drug: Native human Glucagon-like Peptide-1 ( GLP-1(7-36));   Drug: NaCl
9 Not yet recruiting Acute Exercise and Glucotoxicity
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Interventions: Behavioral: Exercise;   Procedure: Hyperglycemia
10 Not yet recruiting User Evaluation of the MiniMed 620G Insulin Pump
Conditions: Type 1 Diabetes;   Type 2 Diabetes
Intervention: Device: Medtronic MiniMed 620G Insulin Pump
11 Recruiting Recurrent Hypoglycaemia in Type 1 Diabetes
Condition: Hypoglycaemia
Intervention: Procedure: Insulin clamp
12 Recruiting A Pilot Study of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
Condition: Diabetic Nephropathies
Interventions: Drug: Allopurinol;   Drug: Placebo
13 Not yet recruiting Magnetic Resonance Diagnostics of Diabetic Peripheral Neuropathy
Conditions: Diabetes Mellitus, Type 1;   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy;   Hereditary Axonal Neuropathy;   Hereditary Demyelinated Neuropathy;   Polyneuropathy, Inflammatory Demyelinating, Chronic
Intervention:
14 Not yet recruiting Diameter Changes of Retinal Vessels During Hypoxia
Conditions: Diabetes Mellitus Type 1;   Retinal Branch Vein Occlusion
Interventions: Other: COX inhibitor;   Other: L-NG-monomethyl arginine citrate;   Other: COX inhibitor + L-NG-monomethyl arginine citrate
15 Recruiting GIP and GLP-1 in Type 1 Diabetes
Condition: Hypoglycemia
Interventions: Other: GIP;   Other: GLP-1;   Other: Saline
16 Not yet recruiting Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4
Conditions: Diabetes Mellitus Type I;   Diabetes Mellitus Type II
Intervention: Device: Integrated sensor and infusion set.
17 Recruiting Vasodilatatory and Metabolic Effects of Glucagon-like Peptide-1 in Perphery Circulation in Patients With and Without Type 2 Diabetes Mellitu
Conditions: Type 2 Diabetes;   Blod Pressure;   Glucagon-like Peptide-1;   Human Physiology;   Blood Flow
Interventions: Other: human glucagon-like peptide 1 (7-36)amide;   Other: human glucagon-like peptide 1 (9-36)amide
18 Recruiting The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride Metabolism
Conditions: Type 2 Diabetes;   Dyslipidemia
Interventions: Drug: Insulin;   Drug: insulin;   Other: diet;   Other: no diet
19 Recruiting The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Other: Training and liraglutide;   Other: Training and placebo
20 Unknown  GPR 119 Stimulated GLP-1 Secretion
Conditions: Type 2 Diabetes;   Endogenous GLP-1 Secretion
Interventions: Dietary Supplement: A lipid shown to act specifically by the GPR 119 receptor;   Dietary Supplement: Active comparator

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years